A5075425276- Renal Diseases and Glomerulopathies
- Genetic and Kidney Cyst Diseases
- Vasculitis and related conditions
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Pediatric Urology and Nephrology Studies
- Parathyroid Disorders and Treatments
- Autoimmune Bullous Skin Diseases
- Otitis Media and Relapsing Polychondritis
- Cerebrospinal fluid and hydrocephalus
- Eosinophilic Disorders and Syndromes
- Transplantation: Methods and Outcomes
- Blood disorders and treatments
- Systemic Lupus Erythematosus Research
- Inflammatory Bowel Disease
- Bartonella species infections research
- Celiac Disease Research and Management
- Cystic Fibrosis Research Advances
- Reproductive tract infections research
- Acute Kidney Injury Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Renal cell carcinoma treatment
- Autoimmune and Inflammatory Disorders
- Complement system in diseases
- Pelvic floor disorders treatments
- Lysosomal Storage Disorders Research
Institut de Transplantation Urologie en Nephrologie
2019-2025
Nantes Université
2021-2024
Centre Hospitalier Universitaire de Nantes
2018-2024
Centre d'Investigation Clinique de Nantes
2018-2024
Center for Research in Transplantation and Translational Immunology
2022
Centre Hospitalier Saint-Nazaire
2022
Inserm
2022
RELX Group (United States)
2022
Avacopan, a selective C5aR1 inhibitor, recently emerged as glucocorticoid (GCs) sparing agent in ANCA-associated vasculitis (AAV). We aim to evaluate the tolerance and efficacy of avacopan given outside randomized clinical trials or with severe kidney involvement.
BackgroundIgA nephropathy associated with cirrhosis is frequent but often overlooked as largely considered silent. Until now, little has been known about their presentation and outcomes.MethodsWe conducted a retrospective multicenter study on patients kidney biopsy-proven cirrhosis-related IgA (cirrhosis-IgAN), diagnosed between 2009 2022. We mixed them up 83 primary (pIgAN) during the same period, using partitioning clustering approach, to determine common clinicopathological...
Cyst infection is a known complication of autosomal dominant polycystic kidney disease (ADPKD). Here, we describe incidence, risk factors, clinical presentation, and outcomes cyst in transplant recipient.We conducted single-center retrospective cohort study patients with ADPKD renal allografts between January 1, 2009, October 31, 2020. diagnosis was based on previously described radiological criteria, using positron emission tomography when available.A total 296 were included, 21 experienced...
<h3></h3> In France, few data on prevalence of <i>Trichomonas vaginalis</i> in the general population as well high-risk populations exist. We determined (TV) together with <i>Chlamydia trachomatis</i> (CT) and <i>Neisseria gonorrhoeae</i> (NG) prevalence, men women or without symptoms sexually transmitted infection (STI), undergoing CT NG screening France. 683 2432 were enrolled a basis either urethral, cervical vaginal swabs, urine sperm samples, using APTIMA Trichomonas vaginalis assay...
We agree with Geertsema et al.1Geertsema P, Leliveld AM, Casteleijn NF, The presence of kidney cyst infections in ADPKD patients after transplantation: need for urological analysis? Kidney Inter Reports. 2022;7:1924. https://doi.org/10.1016/j.ekir.2022.03.039.Google Scholar when they point out that prophylactic unilateral nephrectomy case a history infection before transplantation may be an overtreatment. As stated, did not prevent recurrence the post-transplantation period our retrospective...